(MET) MetLife - Ratings and Ratios

MetLife, Inc. (NYSE: MET), a global leader in financial services, specializes in insurance, annuities, employee benefits, and asset management solutions. Operating across six distinct segments—Group Benefits; Retirement and Income Solutions; Asia; Latin America; Europe, the Middle East and Africa (EMEA); and MetLife Holdings—the company delivers a comprehensive suite of products and services tailored to individual and institutional clients worldwide.

The company’s extensive product portfolio includes life, dental, disability, and vision insurance; prepaid legal plans; administrative services-only (ASO) arrangements; and a range of annuity and pension solutions. It also offers structured settlements, capital markets investment products, and reinsurance solutions. Additionally, MetLife provides funding agreements for postretirement benefits and company-owned life insurance (COLI) programs for executive benefit plans. Its offerings extend to credit insurance, critical illness coverage, long-term care solutions, and hospitalization plans, underscoring its commitment to risk management and financial security across diverse customer needs.

As one of the world’s largest life insurance companies, MetLife serves over 100 million customers globally, with a significant presence in the Asia-Pacific region, Latin America, and Europe. Incorporated in 1999 and headquartered in New York, the company has established itself as a key player in the global insurance and financial services industry. Its operational scale and diversified product range enable it to address evolving market demands while maintaining a strong competitive position. Web URL: https://www.metlife.com

Ticker Symbol: MET
Exchange: NYSE
Type: common stock
Country Origin: United States
GICS Sub Industry: Life & Health Insurance

3 Month Forecast:
Based on current trends, MET is expected to face headwinds in the near term. The stock is trading below its 20, 50, and 200-day SMAs, indicating bearish momentum. The average true range (ATR) of 3.15 suggests moderate volatility, with potential downside risks if support levels near $68 are breached.
Despite this, MET’s forward P/E of 7.68 and return on equity (RoE) of 16.13 highlight attractive valuations and strong profitability. These fundamentals may provide a floor for the stock, making it a potential value play in the next quarter.